Gynecologic Oncology at ASCO 2022: Subgroup Analysis of KEYNOTE-826

Gynecologic oncology session co-chair Debra L. Richardson, MD, from University of Oklahoma Health Sciences Center, discusses "Pembrolizumab + chemotherapy in patients with persistent, recurrent, or metastatic cervical cancer: Subgroup analysis of KEYNOTE-826," which was presented by Krishnansu Sujata Tewari, MD, FACS, FACOG, at the ASCO 2022 Annual Meeting.